PRESS RELEASE : Fresenius Medical Care AG & Co. KGaA published form 20-F for the fiscal year 2020

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Annual Results 
Fresenius Medical Care AG & Co. KGaA published form 20-F for the fiscal year 2020 
2021-02-24 / 10:51 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has 
filed the annual report 2020 on form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is 
available at the company's website (freseniusmedicalcare.com) in the "Investors" section as well as at the SEC's 
website (www.sec.gov). 
A hard copy of Fresenius Medical Care's annual report on form 20-F including the complete audited financial statements 
may be obtained from the company free of charge upon request to the company's Investor Relations department by email at 
[e-mail]. 
The company also published a Facts & Figures 2020 website at factsandfigures.fmc-ag.com to provide an overview of the 
key financial figures for the fiscal year 2020. In addition, the new Corporate Magazine, Company Profile as well as a 
Five-Year-Summary are available for download. 
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of 
which around 3.7 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,092 dialysis 
clinics, Fresenius Medical Care provides dialysis treatments for 346,553 patients around the globe. Fresenius Medical 
Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core 
business, the Renal Care Continuum, the company focuses on expanding in complementary areas and in the field of 
critical care. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock 
Exchange (FMS). 
For more information visit the Company's website at www.freseniusmedicalcare.com and factsandfigures.fmc-ag.com. 
Disclaimers 
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results 
could differ materially from those described in these forward-looking statements due to various factors, including, but 
not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results 
of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and 
the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. 
KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not 
undertake any responsibility to update the forward-looking statements in this release. 
Contact: 
Dr. Dominik Heger 
EVP I Head of Investor Relations, Strategic Development & Communications 
[e-mail] 
P. [phone] 
=---------------------------------------------------------------------------------------------------------------------- 
2021-02-24 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Fresenius Medical Care AG & Co. KGaA 
              Else-Kröner-Straße 1 
              61352 Bad Homburg 
              Germany 
Phone:        [phone] 
Fax:          [phone] 
E-mail:       [e-mail] 
Internet:     www.freseniusmedicalcare.com 
ISIN:         DE0005785802 
WKN:          578580 
Indices:      DAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange 
EQS News ID:  1170744 
 
End of News   DGAP News Service 
=------------ 

1170744 2021-02-24

(END) Dow Jones Newswires

February 24, 2021 04:53 ET (09:53 GMT)